Realbotix Aktie

Realbotix recorded a revenue decline in Q3 2026, which management mainly attributes to the end of its crypto-staking business and a change in revenue recognition for order backlogs. The company has completed its move to a new manufacturing facility and is preparing to launch a four-model robot line in the fall, including a tabletop model for $12,000 and a life-size model for about $55,000. Realbotix is also pursuing a listing via a transaction with Onconetix; an S-4 filing is expected shortly. Despite strong short-term liquidity (current ratio 5.8), the company shows a negative gross margin of -46% and declining annual revenues of $1.05m (down 46%), so the shift to commercialization and scaling direct sales will be critical for its future. » Więcej na de.investing.com

Realbotix builds expensive AI-powered humanoids with highly detailed silicone faces and dozens of motors to create realistic expressions. In tests the robots delivered surprising jokes and language flexibility, yet long response delays and poor recognition of users' emotions revealed limits in conversational naturalness. The company says it is still refining the technology as it sells early-generation models for applications like events and customer-facing roles. » Więcej na tech.yahoo.com

Realbotix announced a strategic realignment toward AI and humanoid robotics in its Q2 earnings call, saying it has paid down all debt and secured operating capital for more than 12 months. Management does not expect short-term revenue growth; instead it presented a 3–4 year plan targeting quarterly revenue of $100 million. The company plans a Nasdaq listing via a reverse merger with Onco, cites supply bottlenecks for NVIDIA Thor processors as a risk, and currently values itself at around $55 million; the stock was trading near its 52-week low. » Więcej na de.investing.com